Surprisingly, both oxidative phosphorylation pathway and ribosome pathway were most statistically significantly associated with experiments involving the inhibition of ACTL6A and BRD9. These results indicated that the amplification of both BRD9 and ACTL6A affect these essential biological pathways in human cancers. The gene discussed is BRD9; the disease is cancer.